bioAffinity Technologies (BIAF) Cost of Revenue (2022 - 2025)
Historic Cost of Revenue for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $942211.0.
- bioAffinity Technologies' Cost of Revenue fell 3457.59% to $942211.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 1967.3%. This contributed to the annual value of $6.0 million for FY2024, which is 24370.33% up from last year.
- As of Q3 2025, bioAffinity Technologies' Cost of Revenue stood at $942211.0, which was down 3457.59% from $1.0 million recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Cost of Revenue ranged from a high of $1.7 million in Q4 2023 and a low of $87.0 during Q1 2023
- Moreover, its 4-year median value for Cost of Revenue was $979406.5 (2025), whereas its average is $789392.8.
- As far as peak fluctuations go, bioAffinity Technologies' Cost of Revenue surged by 180845287.36% in 2024, and later tumbled by 3457.59% in 2025.
- Quarter analysis of 4 years shows bioAffinity Technologies' Cost of Revenue stood at $175.0 in 2022, then surged by 951248.0% to $1.7 million in 2023, then decreased by 6.17% to $1.6 million in 2024, then plummeted by 39.69% to $942211.0 in 2025.
- Its Cost of Revenue was $942211.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.4 million in Q1 2025.